Literature DB >> 28395106

Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Dita Gratzinger1, Elaine S Jaffe2, Amy Chadburn3, John K C Chan4, Daphne de Jong5, John R Goodlad6, Jonathan Said7, Yasodha Natkunam1.   

Abstract

OBJECTIVES: The 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology aimed to review primary immunodeficiency and related lymphoproliferations.
METHODS: Primary immunodeficiencies were divided into immune dysregulation, DNA repair defects, low immunoglobulins, and combined immunodeficiencies.
RESULTS: Autoimmune lymphoproliferative syndrome (ALPS) is a prototypical immune dysregulation-type immunodeficiency, with defects in T-cell signaling or apoptosis, expansion of T-cell subsets, and predisposition to hemophagocytic lymphohistiocytosis. DNA repair defects directly predispose to malignancy. Low immunoglobulin immunodeficiencies such as common variable immunodeficiency (CVID) have underlying T-cell repertoire abnormalities predisposing to autoimmunity and B-cell lymphoproliferations. The full spectrum of B-cell lymphoproliferative disorders occurs in primary immunodeficiency.
CONCLUSIONS: Lymphoproliferations in primary immunodeficiency mirror those in other immunodeficiency settings, with monomorphic B- and sometimes T lymphoproliferative disorders enriched in DNA repair defects. Distinctive T-cell subset expansions in ALPS, CVID, and related entities can mimic lymphoma, and recognition of double-negative T-cell or cytotoxic T-cell expansions is key to avoid overdiagnosis. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Autoimmune lymphoproliferative syndrome; Common variable immunodeficiency; Double negative T cells; Primary immunodeficiency; T-cell lymphoma

Mesh:

Year:  2017        PMID: 28395106      PMCID: PMC6248572          DOI: 10.1093/ajcp/aqw215

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  68 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 2.  Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Authors:  Kim E Nichols; Cindy S Ma; Jennifer L Cannons; Pamela L Schwartzberg; Stuart G Tangye
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

3.  Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.

Authors:  Masatoshi Takagi; Kunihiro Shinoda; Jinhua Piao; Noriko Mitsuiki; Mari Takagi; Kazuyuki Matsuda; Hideki Muramatsu; Sayoko Doisaki; Masayuki Nagasawa; Tomohiro Morio; Yoshihito Kasahara; Kenichi Koike; Seiji Kojima; Akira Takao; Shuki Mizutani
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

4.  Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia.

Authors:  K Washington; T T Stenzel; R H Buckley; M R Gottfried
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

5.  High-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia.

Authors:  Manish Ramesh; Noa Simchoni; David Hamm; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2015-09-07       Impact factor: 3.969

6.  γδ T Cells Shape Preimmune Peripheral B Cell Populations.

Authors:  Yafei Huang; Andrew Getahun; Ryan A Heiser; Thiago O Detanico; Katja Aviszus; Greg A Kirchenbaum; Tamara L Casper; Chunjian Huang; M Kemal Aydintug; Simon R Carding; Koichi Ikuta; Hua Huang; Lawrence J Wysocki; John C Cambier; Rebecca L O'Brien; Willi K Born
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

7.  Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.

Authors:  Vanessa Szablewski; Céline René; Valérie Costes
Journal:  Virchows Arch       Date:  2015-10-22       Impact factor: 4.064

8.  Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome.

Authors:  Rita Carsetti; Diletta Valentini; Valentina Marcellini; Marco Scarsella; Emiliano Marasco; Ferruccio Giustini; Andrea Bartuli; Alberto Villani; Alberto G Ugazio
Journal:  Eur J Immunol       Date:  2014-12-28       Impact factor: 5.532

9.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 10.  Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.

Authors:  Laura Dotta; Silvia Parolini; Alberto Prandini; Giovanna Tabellini; Maddalena Antolini; Stephen F Kingsmore; Raffaele Badolato
Journal:  Orphanet J Rare Dis       Date:  2013-10-17       Impact factor: 4.123

View more
  8 in total

1.  Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited.

Authors:  Vincent Allain; Virginie Grandin; Véronique Meignin; Rémi Bertinchamp; David Boutboul; Claire Fieschi; Lionel Galicier; Laurence Gérard; Marion Malphettes; Jacinta Bustamante; Mathieu Fusaro; Nathalie Lambert; Jérémie Rosain; Christelle Lenoir; Sven Kracker; Frédéric Rieux-Laucat; Sylvain Latour; Jean-Pierre de Villartay; Capucine Picard; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2022-09-26       Impact factor: 8.542

Review 2.  Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know.

Authors:  Saniya Sharma; Rakesh Kumar Pilania; Gummadi Anjani; Murugan Sudhakar; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 3.  Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Authors:  Yasodha Natkunam; Dita Gratzinger; Amy Chadburn; John R Goodlad; John K C Chan; Jonathan Said; Elaine S Jaffe; Daphne de Jong
Journal:  Blood       Date:  2018-08-06       Impact factor: 22.113

4.  T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.

Authors:  Dita Gratzinger; Daphne de Jong; Elaine S Jaffe; Amy Chadburn; John K C Chan; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

5.  Establishment of the Reference Intervals of Lymphocyte Function in Healthy Adults Based on IFN-γ Secretion Assay upon Phorbol-12-Myristate-13-Acetate/Ionomycin Stimulation.

Authors:  Hongyan Hou; Yu Zhou; Jing Yu; Lie Mao; Munyemana Jean Bosco; Juan Wang; Yanfang Lu; Liyan Mao; Xiaohui Wu; Feng Wang; Ziyong Sun
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

6.  Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature.

Authors:  Marieke L Nijland; Lianne Koens; Steven T Pals; Ineke J M Ten Berge; Frederike J Bemelman; Marie José Kersten
Journal:  Haematologica       Date:  2017-12-21       Impact factor: 9.941

Review 7.  Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group.

Authors:  Simon Bomken; Jutte van der Werff Ten Bosch; Andishe Attarbaschi; Chris M Bacon; Arndt Borkhardt; Kaan Boztug; Ute Fischer; Fabian Hauck; Roland P Kuiper; Tim Lammens; Jan Loeffen; Bénédicte Neven; Qiang Pan-Hammarström; Isabella Quinti; Markus G Seidel; Klaus Warnatz; Claudia Wehr; Arjan C Lankester; Andrew R Gennery
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

8.  Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.

Authors:  Arnaud C Drouin; Marc W Theberge; Sharon Y Liu; Allison R Smither; Shelby M Flaherty; Mark Zeller; Gregory P Geba; Peter Reynaud; W Benjamin Rothwell; Alfred P Luk; Di Tian; Matthew L Boisen; Luis M Branco; Kristian G Andersen; James E Robinson; Robert F Garry; Dahlene N Fusco
Journal:  Viruses       Date:  2021-06-23       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.